Getty Images
It's been a big week for women’s sexual health. A drug that promised to ignite sexual desire in women is getting put on the back burner by the FDA. Meanwhile, the FDA cleared the way for a pill that gives women a few days more wiggle room in preventing pregnancy after unprotected sex.
On Thursday, FDA advisers recommended that the agency approve the “morning-after” pill ella, which can prevent pregnancy up to five days after unprotected sex. One day later, an FDA panel rejected the much-anticipated “female Viagra” drug flibanserin, stating that the drug failed to offer any real boost in sexual desire.
